Literature DB >> 8408776

Early events following challenge of rabbits with Trypanosoma evansi and T. evansi components.

U E Uche1, T W Jones.   

Abstract

The intradermal injection of Trypanosoma evansi or T. evansi components into rabbits evoked trypanosome-specific responses in the skin. The strongest responses, which were those against the parasite surface-associated components, had the characteristics of an immediate type hypersensitivity reaction, followed by a delayed type. The responses were greater in rabbits from which infections had been cleared by chemotherapy than in animals with patient infections. These findings suggest that variant surface glycoprotein (VSG)-specific antibody activity and immunosuppression are effective in the skin and influence the outcome of infection with T. evansi in previously infected animals.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8408776     DOI: 10.1016/s0021-9975(08)80235-6

Source DB:  PubMed          Journal:  J Comp Pathol        ISSN: 0021-9975            Impact factor:   1.311


  3 in total

1.  Trypanosomosis research at the Centre for Tropical Veterinary Medicine (CTVM) 1970 to 1995.

Authors:  R Boid; A G Hunter; T W Jones; C A Ross; D Sutherland; A G Luckins
Journal:  Trop Anim Health Prod       Date:  1996-02       Impact factor: 1.559

2.  Low Dose Gamma Irradiation of Trypanosoma evansi Parasites Identifies Molecular Changes That Occur to Repair Radiation Damage and Gene Transcripts That May Be Involved in Establishing Disease in Mice Post-Irradiation.

Authors:  Richard T Kangethe; Eva M Winger; Tirumala Bharani K Settypalli; Sneha Datta; Viskam Wijewardana; Charles E Lamien; Hermann Unger; Theresa H T Coetzer; Giovanni Cattoli; Adama Diallo
Journal:  Front Immunol       Date:  2022-05-13       Impact factor: 8.786

3.  Pathological studies on experimental Trypanosoma evansi infection in Swiss albino mice.

Authors:  Mandeep Singh Bal; L D Singla; H Kumar; Ashuma Vasudev; K Gupta; P D Juyal
Journal:  J Parasit Dis       Date:  2012-06-04
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.